TOWERVIEW LLC - BIOTA PHARMACEUTIALS INC ownership

Quarter-by-quarter ownership
TOWERVIEW LLC ownership history of BIOTA PHARMACEUTIALS INC
ValueSharesWeighting
Q1 2016$240,000
-22.6%
160,0000.0%0.12%
-29.1%
Q4 2015$310,000
-2.2%
160,0000.0%0.16%0.0%
Q3 2015$317,000
-4.2%
160,0000.0%0.16%
+3.1%
Q2 2015$331,000
-10.1%
160,0000.0%0.16%
-4.2%
Q1 2015$368,000
+2.8%
160,0000.0%0.17%
+5.7%
Q4 2014$358,000
-9.4%
160,0000.0%0.16%
-29.8%
Q3 2014$395,000
-99.9%
160,000
-28.9%
0.22%
-26.5%
Q2 2014$641,000,000
-25.0%
225,000
+60.7%
0.31%
-21.3%
Q1 2014$855,000,000
-28.4%
140,000
-50.9%
0.39%
-28.8%
Q4 2013$1,194,000,000
+0.3%
285,0000.0%0.55%
-5.4%
Q3 2013$1,191,000,000
+21.2%
285,0000.0%0.58%
+49.5%
Q2 2013$983,000,000285,0000.39%
Other shareholders
BIOTA PHARMACEUTIALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SENZAR ASSET MANAGEMENT, LLC 1,407,700$3,153,0000.92%
Broadfin Capital, LLC 5,223,422$11,700,0000.51%
Avoro Capital Advisors LLC 258,586$579,0000.39%
RA Capital Management 1,378,770$3,088,0000.33%
BVF INC/IL 435,900$976,0000.19%
Dominick & Dominick LLC 150,166$336,0000.17%
TOWERVIEW LLC 160,000$358,0000.16%
KNOTT DAVID M 268,327$601,052,0000.14%
GABELLI & Co INVESTMENT ADVISERS, INC. 292,807$656,0000.09%
Baker Brothers Advisors 1,106,910$2,479,0000.02%
View complete list of BIOTA PHARMACEUTIALS INC shareholders